Trial intelligence / Profile preview

DW1903 in Patients With Gastritis

NCT05163756Phase 3Completed

Sponsor
Daewon Pharm
Start
Nov 2020
Primary completion
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of esomeprazole in gastritis, sponsored by Daewon Pharm. Started Nov 2020; status: completed.

02

Drugs

esomeprazole
03

Conditions

gastritis

Beyond the preview

Go deeper on NCT05163756.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05163756.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call